Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
68,652,138
-
Total 13F shares
-
912,180
-
Share change
-
-1,314,332
-
Total reported value
-
$5,265,087
-
Price per share
-
$5.81
-
Number of holders
-
21
-
Value change
-
-$7,635,044
-
Number of buys
-
15
-
Number of sells
-
4
Institutional Holders of Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) as of Q1 2021
As of 31 Mar 2021,
Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
912,180 shares.
The largest 10 holders included
Altium Capital Management LP, Ikarian Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, NORRIS PERNE & FRENCH LLP/MI, PURA VIDA INVESTMENTS, LLC, COMERICA BANK, Regency Capital Management Inc.\DE, VANGUARD GROUP INC, BOOTHBAY FUND MANAGEMENT, LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
21
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.